Pfizer’s twice-daily weight loss pill joins a long list of obesity drug flops
Before successful weight loss treatments such as Wegovy and Ozempic, the pharmaceutical path to treating obesity was strewn with failures dating back decades.
Similar Posts
North Korea says it will not negotiate sovereignty with ‘double-faced’ US
Post Content Post Views: 111
Activist investor Elliott takes more than $2B stake in Crown Castle – WSJ
Post Content Post Views: 97
Invesco 1-30 Laddered Treasury ETF declares monthly distribution of $0.0820
Post Content Post Views: 105
Ousted OpenAI head Sam Altman to lead Microsoft’s new AI team
Former OpenAI CEO Sam Altman will be joining Microsoft to lead a new advanced AI research team, according to Microsoft CEO Satya Nadella. Post Views: 120
HP CEO: Growth in PC segment likely to double next year
Post Content Post Views: 130
US stocks drift lower; retailers in focus as holiday sales season starts
Post Content Post Views: 97